dimanche 15 novembre 2026
RechercherExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· January 27, 2026

GM (GM) Q4 2025 Earnings Call Transcript

View original at finance.yahoo.com
GM (GM) Q4 2025 Earnings Call Transcript Image source: The Motley Fool. Date Jan. 27, 2026, at 8:30 a.m…
Opening lines of the source · short snapshot: read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Chinese OEMs are heavily subsidized creating pressure in LATAM and other markets

    80% confidence
  • LMR battery chemistry will reduce cell/pack cost by several thousand dollars

    80% confidence
  • 6th-gen V8 achieves 20% material/tooling cost savings

    80% confidence
  • EV adoption will grow over time enabled by charging infrastructure expansion (L2 chargers increased 25% in 2025)

    80% confidence
  • GM continues to believe in electric vehicles

    80% confidence
  • Warranty trends are positive and moving in the right direction with monthly cash flows stable/flattening

    80% confidence
  • GM will achieve 2M units of future US production capacity annually, which is industry-leading

    80% confidence
  • GM has everything needed to deliver a safe, reliable, and highly capable autonomous system

    80% confidence
  • L87 V8 fixes (oil change, dealership testing) showing really good progress

    80% confidence
  • Super Cruise renewal rate is in low 40% range

    80% confidence
  • Historical norm of a giant price increase for model year really doesn't hold in low-inventory environment

    80% confidence
  • 2026 EV capacity actions will deliver $1-1.5B benefit from lower fixed costs, improved mix, and resolved commercial claims

    80% confidence
  • GM China turnaround described as quick and sustainable

    80% confidence
  • GM 2026 gross tariff forecast is $3-4B assuming 15% Korea tariff vs 25%

    80% confidence
  • 6th-gen V8 development time is 1/3 of prior program due to virtual tools

    80% confidence
  • OnStar/software services will deliver $400M incremental high-margin revenue in 2026

    80% confidence
  • GM demonstrated another true core competency throughout the year: agility and speed in adapting to change

    80% confidence
  • Net tariff exposure in 2026 expected lower than 2025

    80% confidence
  • 2026 regulatory savings from not needing compliance credits will deliver $500-750M benefit

    80% confidence
  • New headquarters saves tens of millions of dollars annually

    80% confidence
  • Recent storm weather affected production likely for everybody with makeup work planned

    80% confidence
  • Safety is key to building trust in new technologies

    80% confidence
  • GM valuation levels are back to historical norms but remain well below peers

    80% confidence
  • GM has a clear and achievable path back to 8-10% North America margins in 2026

    80% confidence
  • 2026 warranty improvement will deliver $1B benefit

    80% confidence
  • Policy actions supported companies with substantial and growing commitments to American manufacturing

    80% confidence
  • GM management team has what it takes to respond and meet the consumer where they are

    80% confidence
  • EVs brought approximately 100K new customers to GM in 2025

    80% confidence
  • 2,500 robots/cobots deployed controlled by GM-designed software

    80% confidence
  • Repurchasing GM stock at current valuation levels represents one of the most compelling opportunities to generate long-term shareholder value

    80% confidence

Cité dans ces articles de Via News

Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,997
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,997 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com
GM (GM) Q4 2025 Earnings Call Transcript: Source | Via News | fr.via.news